Similar articles for PMID: 19795998

Year	Number of Results
1971	1
1972	1
1979	1
1993	1
1997	1
2003	1
2004	1
2005	5
2006	5
2007	7
2008	7
2009	13
2010	24
2011	16
2012	25
2013	27
2014	22
2015	19
2016	7
2017	8
2018	10
2019	22
2020	4
2021	7
2022	7
2023	2
2024	0

1

Tapentadol immediate release for the relief of moderate-to-severe acute pain.

Hartrick CT. Hartrick CT. Expert Opin Pharmacother. 2009 Nov;10(16):2687-96. doi: 10.1517/14656560903313734. Expert Opin Pharmacother. 2009. PMID: 19795998 Review.

2

Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.

Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D. Hartrick C, et al. Clin Ther. 2009 Feb;31(2):260-71. doi: 10.1016/j.clinthera.2009.02.009. Clin Ther. 2009. PMID: 19302899 Clinical Trial.

3

Tapentadol hydrochloride: a centrally acting oral analgesic.

Wade WE, Spruill WJ. Wade WE, et al. Clin Ther. 2009 Dec;31(12):2804-18. doi: 10.1016/j.clinthera.2009.12.003. Clin Ther. 2009. PMID: 20110020 Review.

4

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.

Daniels S, Casson E, Stegmann JU, Oh C, Okamoto A, Rauschkolb C, Upmalis D. Daniels S, et al. Curr Med Res Opin. 2009 Jun;25(6):1551-61. doi: 10.1185/03007990902952825. Curr Med Res Opin. 2009. PMID: 19445652 Clinical Trial.

5

Single dose analgesic efficacy of tapentadol in postsurgical dental pain: the results of a randomized, double-blind, placebo-controlled study.

Kleinert R, Lange C, Steup A, Black P, Goldberg J, Desjardins P. Kleinert R, et al. Anesth Analg. 2008 Dec;107(6):2048-55. doi: 10.1213/ane.0b013e31818881ca. Anesth Analg. 2008. PMID: 19020157 Clinical Trial.

6

Efficacy of tapentadol ER for managing moderate to severe chronic pain.

Afilalo M, Morlion B. Afilalo M, et al. Pain Physician. 2013 Jan;16(1):27-40. Pain Physician. 2013. PMID: 23340531 Free article. Review.

7

Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.

Etropolski M, Kelly K, Okamoto A, Rauschkolb C. Etropolski M, et al. Adv Ther. 2011 May;28(5):401-17. doi: 10.1007/s12325-011-0018-0. Epub 2011 Apr 13. Adv Ther. 2011. PMID: 21494892 Clinical Trial.

8

Tapentadol immediate-release for acute pain.

Hartrick CT. Hartrick CT. Expert Rev Neurother. 2010 Jun;10(6):861-9. doi: 10.1586/ern.10.72. Expert Rev Neurother. 2010. PMID: 20518601 Review.

9

Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.

Biondi D, Xiang J, Benson C, Etropolski M, Moskovitz B, Rauschkolb C. Biondi D, et al. Pain Physician. 2013 May-Jun;16(3):E237-46. Pain Physician. 2013. PMID: 23703422 Free article. Clinical Trial.

10

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study.

Buynak R, Shapiro DY, Okamoto A, Van Hove I, Rauschkolb C, Steup A, Lange B, Lange C, Etropolski M. Buynak R, et al. Expert Opin Pharmacother. 2010 Aug;11(11):1787-804. doi: 10.1517/14656566.2010.497720. Expert Opin Pharmacother. 2010. PMID: 20578811 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

230 results

Results by year